Dr. Birrer on Prevalence of Cervical Cancer in the United States

Michael Birrer, MD, PhD
Published: Monday, Jan 09, 2017



Michael Birrer, MD, PhD, director of Medical Gynecologic Oncology at Massachusetts General Hospital, discusses the prevalence of cervical cancer in the United States.

Cervical cancer is viewed as a rare tumor in the United States. There are about 8000 cases annually, with approximately 4800 deaths, Birrer says. Because of that, it is very difficult to get industry partners interested in the field for therapeutic developments. However, this disease requires funding and novel therapies for these patients.

From a worldwide perspective, there are several countries in which drugs will not be able to be developed in or have the funding for such agents. These are examples of the challenges ahead, he explains.


Michael Birrer, MD, PhD, director of Medical Gynecologic Oncology at Massachusetts General Hospital, discusses the prevalence of cervical cancer in the United States.

Cervical cancer is viewed as a rare tumor in the United States. There are about 8000 cases annually, with approximately 4800 deaths, Birrer says. Because of that, it is very difficult to get industry partners interested in the field for therapeutic developments. However, this disease requires funding and novel therapies for these patients.

From a worldwide perspective, there are several countries in which drugs will not be able to be developed in or have the funding for such agents. These are examples of the challenges ahead, he explains.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Best Practice™: Choosing Therapies for Patients with EGFR-Mutant Lung Cancers: More Options... More Decisions... Better OutcomesFeb 28, 20182.0
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Publication Bottom Border
Border Publication
x